company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3786000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3786000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,135000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,55000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-273000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,101000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3768000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3768000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-98000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1882000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1882000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1889000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4194000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4194000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-110000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,512000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,910000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2594000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2594000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-189000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-189000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-189000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1046000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-220000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-80000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,57000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55654000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55654000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52871000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6719000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6719000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,181000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,733000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5629000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5629000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-221000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-221000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-221000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1076000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1226000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,46000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2267000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2267000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8117000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,771000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8168000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8168000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40059000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2495000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37766000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37766000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,779000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-762000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-45917000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12325000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12325000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1003000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7500000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6481000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6481000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,96000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5748000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,194000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14084000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14084000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,164000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,21000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2345000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,907000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10647000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10647000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-434000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7500000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7066000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7066000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,224000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-75000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,149000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,149000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:15:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3432000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16176000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,175000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,32000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2696000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1705000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11568000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11568000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-205000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36130000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,264000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31071000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31071000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45912000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,150000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45912000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45912000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3273000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16944000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16944000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,190000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,47000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2333000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1060000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13314000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13314000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-356000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40644000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40644000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-295000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-295000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-295000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27035000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,198000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2358000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13270000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13270000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-139000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16764000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-264000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16362000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16362000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3115000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15693000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15693000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,207000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2385000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1202000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14267000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14267000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-127000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20016000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5500000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14643000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14643000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,493000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-27000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,466000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,466000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:10:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28444000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11275000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11275000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-152000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12848000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12848000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1573000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11615000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11615000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14904000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14904000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3357000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14022000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14022000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,213000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2098000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,113000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11590000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11590000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15015000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11679000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14201000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14201000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,158000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2058000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1031000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13009000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13009000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14942000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14942000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,75000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,75000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 16:06:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2008000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,205000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-42000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2026000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-853000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13889000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13889000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49908000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39908000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39908000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,69700000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,69723000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,69701000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15904000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15033000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15033000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,208000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-71000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1970000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,451000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12475000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12475000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14945000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4980000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4980000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-322000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7817000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15741000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15741000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,207000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-63000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1716000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7927000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5954000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5954000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24866000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,134000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,134000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-23000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43300000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43277000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43277000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,37457000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15579000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15579000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,195000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-90000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1747000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2724000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16451000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16451000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-134000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9924000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9924000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,667000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-35000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,632000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,632000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:47:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25743000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35643000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35643000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,198000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-105000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20997000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1269000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15822000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15822000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14961000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14961000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,241000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,241000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,241000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-620000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19020000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,187000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-195000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6050000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1909000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11069000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11069000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-72000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-108909000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-93981000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-93981000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,109023000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,70000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,109093000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,109023000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3973000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18611000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18611000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-736000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-91000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80884000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,61640000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,61640000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-114000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-144673000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-113787000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-113787000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-703000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60690000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-70000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59917000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59987000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7840000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26154000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,242000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1225000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5684000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,105108000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,72287000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,72287000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2280000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49451000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,88000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36269000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36269000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-50000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,196000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,146000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,146000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:31:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,108702000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23845000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23845000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,297000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1072000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3868000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5303000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26055000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26055000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1576000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-172835000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34411000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34411000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,646000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,646000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,646000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59820000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30790000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,337000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-882000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4970000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5635000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1458000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-97633000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78000000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21091000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21091000.0
Dicerna Pharmaceuticals Inc,DRNA,549300CTZMJMPH28WN39,0001399529,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53091000.0
